Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

COVID symptoms this summer look a lot like symptoms from earlier strains, such as fatigue, runny nose and a headache. “The ...

Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...

Research shows that COVID tends to spike twice annually — once in the winter and once in the summer, and, like past years, ...

COVID-19 cases are rising in 26 states. Is the US in a summer wave? What to know about COVID trends and symptoms of the new ...

Two new COVID-19 variants are spreading across the country and doctors in Connecticut are expecting they could bring an ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

The HK gov't has announced that it will stop sponsoring private doctors to provide free Covid-19 oral antiviral pills from ...

TOKYO -- Roughly 2.5 million doses of oral COVID-19 medication bought by the Japanese government during the pandemic expired and were disposed of by the end of February, Nikkei has learned.

Experts say the summer surge is just starting, but a few key tips can help protect you during vacations and summer parties.

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.